請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/59713
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 李雅珍(Ya-Jane Lee) | |
dc.contributor.author | Yih-Shuang Lin | en |
dc.contributor.author | 林懿雙 | zh_TW |
dc.date.accessioned | 2021-06-16T09:34:24Z | - |
dc.date.available | 2020-02-17 | |
dc.date.copyright | 2017-02-17 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-02-13 | |
dc.identifier.citation | 1. IRIS Grading of Acut Kidney Injury (AKI) Elanco. http://www.iris-kidney.com/guidelines/grading.html.
2. IRIS Staging of CKD Elanco. http://www.iris-kidney.com/guidelines/staging.html. 3. Abbate M, Zoja C, Corna D, Rottoli D, Zanchi C, Azzollini N, Tomasoni S, Berlingeri S, Noris M, Morigi M, and Remuzzi G. Complement-mediated dysfunction of glomerular filtration barrier accelerates progressive renal injury. J Am Soc Nephrol 19: 1158-1167, 2008. 4. Altan E, Cizmecigil UY, Yuzbasioglu Ozturk G, Erdogan O, Tekelioglu KB, Gurel A, Turan N, and Yilmaz H. Presence of feline morbillivirus-RNA in cats in Istanbul, Turkey. Virology unpublished. 5. Arata S, Ohmi A, Mizukoshi F, Baba K, Ohno K, Setoguchi A, and Tsujimoto H. Urinary transforming growth factor-beta1 in feline chronic renal failure. The Journal of veterinary medical science / the Japanese Society of Veterinary Science 67: 1253-1255, 2005. 6. Aresu L, Zanatta R, Pregel P, Caliari D, Tursi M, Valenza F, and Tarducci A. Bilateral juvenile renal dysplasia in a Norwegian Forest Cat. Journal of feline medicine and surgery 11: 326-329, 2009. 7. Bartges J, and Polzin DJ. Nephrology and urology of small animals. Wiley-Blackwell, Chichester, West Sussex, UK ; Ames, Iowa, xvi, 904 p., 2011. 8. Baxter KJ, Levy JK, Edinboro CH, Vaden SL, and Tompkins MB. Renal disease in cats infected with feline immunodeficiency virus. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 26: 238-243, 2012. 9. Beineke A, Puff C, Seehusen F, and Baumgartner W. Pathogenesis and immunopathology of systemic and nervous canine distemper. Veterinary immunology and immunopathology 127: 1-18, 2009. 10. Bergstrom J, and Furst P. Uremic toxins. Kidney Int Suppl S9-12, 1978. 11. Boyd LM, Langston C, Thompson K, Zivin K, and Imanishi M. Survival in cats with naturally occurring chronic kidney disease (2000-2002). Journal of Veterinary Internal Medicine 22: 1111-1117, 2008. 12. Brown S, Atkins C, Bagley R, Carr A, Cowgill L, Davidson M, Egner B, Elliott J, Henik R, Labato M, Littman M, Polzin D, Ross L, Snyder P, and Stepien R. Guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. Journal of Veterinary Internal Medicine 21: 542-558, 2007. 13. Brown SA. BSAVA Manual of Canine and Feline Nephrology and Urology. British Small Animal Veterinary Association, Gloucester, England, 2007. 14. Buffington CA, and Pacak K. Increased plasma norepinephrine concentration in cats with interstitial cystitis. J Urol 165: 2051-2054, 2001. 15. Chakrabarti S, Syme HM, Brown CA, and Elliott J. Histomorphometry of feline chronic kidney disease and correlation with markers of renal dysfunction. Veterinary pathology 50: 147-155, 2013. 16. Chakrabarti S, Syme HM, and Elliott J. Clinicopathological variables predicting progression of azotemia in cats with chronic kidney disease. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 26: 275-281, 2012. 17. Chew D, and Buffington C. Diagnostic approach to cats with lower urinary tract signs. In: Hill’s Global Symposium on Feline Lower Urinary Tract Health Proceedings. Prague: 2014, p. 23-30. 18. Chew DJ, DiBartola SP, Schenck PA, and Chew DJ. Canine and feline nephrology and urology. Elsevier/Saunders, St. Louis, Mo., xi, 526 p., 2011. 19. Cowgill LD, Polzin DJ, Elliott J, Nabity MB, Segev G, Grauer GF, Brown S, Langston C, and van Dongen AM. Is Progressive Chronic Kidney Disease a Slow Acute Kidney Injury? Vet Clin N Am-Small 46: 995- 1013, 2016. 20. Darold GM, Alfieri AA, Muraro LS, Amude AM, Zanatta R, Yamauchi KC, Alfieri AF, and Lunardi M. First report of feline morbillivirus in South America. Archives of virology 2016. 21. DiBartola SP, Rutgers HC, Zack PM, and Tarr MJ. Clinicopathologic findings associated with chronic renal disease in cats: 74 cases (1973-1984). Journal of the American Veterinary Medical Association 190: 1196-1202, 1987. 22. Eddy AA. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 7: 2495-2508, 1996. 23. Eddy AA, and Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47: 1546-1557, 1995. 24. Elliott J, and Barber PJ. Feline chronic renal failure clinical findings in 80 cases diagnosed between 1992 and 1995, Journal of Small Animal Practice Volume 39, Issue 2. Journal of Small Animal Practice 39: 78-85, 1998. 25. Elliott J, Barber PJ, Syme HM, Rawlings JM, and Markwell PJ. Feline hypertension: clinical findings and response to antihypertensive treatment in 30 cases. Journal of Small Animal Practice 42: 122-129, 2001. 26. Ettinger SJ, and Feldman EC. Textbook of veterinary internal medicine. Elsevier Health Sciences, 2009. 27. Fields BN, Knipe DM, and Howley PM. Fields virology. Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, 2007. 28. Finch N. Measurement of glomerular filtration rate in cats: methods and advantages over routine markers of renal function. Journal of feline medicine and surgery 16: 736-748, 2014. 29. Finch NCS, H. M., and Elliott J. The diagnostic utility of routine renal markers for predicting glomerular filtration. In: BSAVA congress. Birmingham, England: 2013, p. 569. 30. Furuya T, Sassa Y, Omatsu T, Nagai M, Fukushima R, Shibutani M, Yamaguchi T, Uematsu Y, Shirota K, and Mizutani T. Existence of feline morbillivirus infection in Japanese cat populations. Archives of virology 159: 371-373, 2014. 31. Furuya T, Wachi A, Sassa Y, Omatsu T, Nagai M, Fukushima R, Shibutani M, Yamaguchi T, Uematsu Y, Shirota K, and Mizutani T. Quantitative PCR detection of feline morbillivirus in cat urine samples. The Journal of veterinary medical science / the Japanese Society of Veterinary Science 2015. 32. Glick AD, Horn RG, and Holscher M. Characterization of feline glomerulonephritis associated with viral-induced hematopoietic neoplasms. The American journal of pathology 92: 321-332, 1978. 33. Gomez-Garre D, Largo R, Tejera N, Fortes J, Manzarbeitia F, and Egido J. Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1. Hypertension 37: 1171-1178, 2001. 34. Greene CE. Infectious diseases of the dog and cat. Elsevier Health Sciences, 2013. 35. Greene JP, Lefebvre SL, Wang M, Yang M, Lund EM, and Polzin DJ. Risk factors associated with the development of chronic kidney disease in cats evaluated at primary care veterinary hospitals. Journal of the American Veterinary Medical Association 244: 320-327, 2014. 36. Habenicht LM, Webb TL, Clauss LA, Dow SW, and Quimby JM. Urinary cytokine levels in apparently healthy cats and cats with chronic kidney disease. Journal of feline medicine and surgery 15: 99-104, 2013. 37. Harris RC, and Neilson EG. Toward a unified theory of renal progression. Annu Rev Med 57: 365-380, 2006. 38. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP, and Duffield JS. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. The American journal of pathology 176: 85-97, 2010. 39. Iseki K, Ikemiya Y, Iseki C, and Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int 63: 1468-1474, 2003. 40. Ishida T, Washizu T, Toriyabe K, Motoyoshi S, Tomoda I, and Pedersen NC. Feline Immunodeficiency Virus-Infection in Cats of Japan. Journal of the American Veterinary Medical Association 194: 221-225, 1989. 41. Iwano M, Plieth D, Danoff TM, Xue C, Okada H, and Neilson EG. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110: 341-350, 2002. 42. Jepson R. Feline systemic hypertension - Classification and pathogenesis. Journal of feline medicine and surgery 13: 25-34, 2011. 43. Jepson RE. Current Understanding of the Pathogenesis of Progressive Chronic Kidney Disease in Cats. The Veterinary clinics of North America Small animal practice 46: 1015-1048, 2016. 44. Jepson RE, Elliott J, Brodbelt D, and Syme HM. Effect of control of systolic blood pressure on survival in cats with systemic hypertension. Journal of Veterinary Internal Medicine 21: 402-409, 2007. 45. Jepson RE, Syme HM, Vallance C, and Elliott J. Plasma asymmetric dimethylarginine, symmetric dimethylarginine, l-arginine, and nitrite/nitrate concentrations in cats with chronic kidney disease and hypertension. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 22: 317-324, 2008. 46. Johnson TS, El-Koraie AF, Skill NJ, Baddour NM, El Nahas AM, Njloma M, Adam AG, and Griffin M. Tissue transglutaminase and the progression of human renal scarring. J Am Soc Nephrol 14: 2052-2062, 2003. 47. Johnson TS, Skill NJ, El Nahas AM, Oldroyd SD, Thomas GL, Douthwaite JA, Haylor JL, and Griffin M. Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol 10: 2146-2157, 1999. 48. Kielstein JT, Salpeter SR, Bode-Boeger SM, Cooke JP, and Fliser D. Symmetric dimethylarginine (SDMA) as endogenous marker of renal function - a meta-analysis. Nephrol Dial Transpl 21: 2446-2451, 2006. 49. Kirk C, and Bartges JW. Feline uroliths and urethral plugs: Epidemiology, risk factors and pathogenesis. In: Hill’s Global Symposium on Feline Lower Urinary Tract Health Proceedings. Prague: 2014, p. 15-22. 50. Koide R, Sakaguchi S, and Miyazawa T. Basic biological characterization of feline morbillivirus. The Journal of veterinary medical science / the Japanese Society of Veterinary Science 77: 565-569, 2015. 51. Koide R, Sakaguchi S, Ogawa M, and Miyazawa T. Rapid detection of feline morbillivirus by a reverse transcription loop-mediated isothermal amplification. The Journal of veterinary medical science / the Japanese Society of Veterinary Science 2015. 52. Kramann R, Dirocco DP, Maarouf OH, and Humphreys BD. Matrix Producing Cells in Chronic Kidney Disease: Origin, Regulation, and Activation. Curr Pathobiol Rep 1: 2013. 53. Lappin MR, Basaraba RJ, and Jensen WA. Interstitial nephritis in cats inoculated with Crandell Rees feline kidney cell lysates. Journal of feline medicine and surgery 8: 353-356, 2006. 54. Lappin MR, Jensen WA, Jensen TD, Basaraba RJ, Brown CA, Radecki SV, and Hawley JR. Investigation of the induction of antibodies against Crandell-Rees feline kidney cell lysates and feline renal cell lysates after parenteral administration of vaccines against feline viral rhinotracheitis, calicivirus, and panleukopenia in cats. American journal of veterinary research 66: 506-511, 2005. 55. Larson J, Kruger JM, Wise AG, Kaneene JB, Miller R, Fitzgerald SD, Kiupel M, and Maes RK. Nested case-control study of feline calicivirus viruria, oral carriage, and serum neutralizing antibodies in cats with idiopathic cystitis. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 25: 199-205, 2011. 56. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, and Kalluri R. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 19: 1047-1053, 2013. 57. Lekcharoensuk C, Osborne CA, and Lulich JP. Epidemiologic study of risk factors for lower urinary tract diseases in cats. Journal of the American Veterinary Medical Association 218: 1429-1435, 2001. 58. Litster A, Moss SM, Honnery M, Rees B, and Trott DJ. Prevalence of bacterial species in cats with clinical signs of lower urinary tract disease: recognition of Staphylococcus felis as a possible feline urinary tract pathogen. Vet Microbiol 121: 182-188, 2007. 59. Little S. Feline Idiopathic Cystitis. In: Little S, ed. August's Consultations in Feline Internal Medicine (Vol 7). Elsevier Health Sciences, St. Louis, MO, 518-525, 2016. 60. Little S. The lower urinary tract. In: ed. The cat: clinical medicine and management. Elsevier Health Sciences, St. Louis, Missouri, 980-1013, 2012. 61. Lorusso A, Di Tommaso M, Di Felice E, Zaccaria G, Luciani A, Marcacci M, Aste G, Boari A, and Savini G. First report of feline morbillivirus in Europe. Veterinaria italiana 51: 235-237, 2015. 62. Lulich JP, Osborne CA, Obrien TD, and Polzin DJ. Feline Renal-Failure - Questions, Answers, Questions. Comp Cont Educ Pract 14: 127-&, 1992. 63. Maclachlan NJ, & Dubovi, E. J. Chapter 17 - Paramyxoviridae. In: Maclachlan NJ, & Dubovi, E. J., ed. Fenner's Veterinary Virology (Fourth Edition). Academic Press, San Diego, 299-325, 2011. 64. Marcacci M, De Luca E, Zaccaria G, Di Tommaso M, Mangone I, Aste G, Savini G, Boari A, and Lorusso A. Genome characterization of feline morbillivirus from Italy. Journal of virological methods 234: 160-163, 2016. 65. McLeland SM, Cianciolo RE, Duncan CG, and Quimby JM. A comparison of biochemical and histopathologic staging in cats with chronic kidney disease. Veterinary pathology 52: 524-534, 2015. 66. Minkus G, Reusch C, Hörauf A, Breuer W, Darbès J, Kraft W, and Hermanns W. Evaluation of renal biopsies in cats and dogs ? histopathology in comparison with clinical data Journal of Small Animal Practice Volume 35, Issue 9. In: Journal of Small Animal Practice1994, p. 465-472. 67. Miyazaki M, Soeta S, Yamagishi N, Taira H, Suzuki A, and Yamashita T. Tubulointerstitial nephritis causes decreased renal expression and urinary excretion of cauxin, a major urinary protein of the domestic cat. Research in veterinary science 82: 76-79, 2007. 68. Olin SJ, and Bartges JW. Urinary tract infections: treatment/comparative therapeutics. The Veterinary clinics of North America Small animal practice 45: 721-746, 2015. 69. Panchaphanpong J, Asawakarn T, and Pusoonthornthum R. Effects of oral administration of N-acetyl-d-glucosamine on plasma and urine concentrations of glycosaminoglycans in cats with idiopathic cystitis. American journal of veterinary research 72: 843-850, 2011. 70. Park ES, Suzuki M, Kimura M, Maruyama K, Mizutani H, Saito R, Kubota N, Furuya T, Mizutani T, Imaoka K, and Morikawa S. Identification of a natural recombination in the F and H genes of feline morbillivirus. Virology 468-470: 524-531, 2014. 71. Park ES, Suzuki M, Kimura M, Mizutani H, Saito R, Kubota N, Hasuike Y, Okajima J, Kasai H, Sato Y, Nakajima N, Maruyama K, Imaoka K, and Morikawa S. Epidemiological and pathological study of feline morbillivirus infection in domestic cats in Japan. BMC veterinary research 12: 228, 2016. 72. Pereira DA, Aguiar JA, Hagiwara MK, and Michelacci YM. Changes in cat urinary glycosaminoglycans with age and in feline urologic syndrome. Biochim Biophys Acta 1672: 1-11, 2004. 73. Poli A, Tozon N, Guidi G, and Pistello M. Renal Alterations in Feline Immunodeficiency Virus (FIV)-Infected Cats: A Natural Model of Lentivirus-Induced Renal Disease Changes. Viruses-Basel 4: 1372-1389, 2012. 74. Polzin DJ. Chronic kidney disease in small animals. The Veterinary clinics of North America Small animal practice 41: 15-30, 2011. 75. Pressler BM. Clinical Approach to Advanced Renal Function Testing in Dogs and Cats. Clin Lab Med 35: 487-502, 2015. 76. Quimby JM, Maranon DG, Battaglia CLR, McLeland SM, Brock WT, and Bailey SM. Feline chronic kidney disease is associated with shortened telomeres and increased cellular senescence. Am J Physiol-Renal 305: F295-F303, 2013. 77. Reche Junior A, and Buffington CA. Increased tyrosine hydroxylase immunoreactivity in the locus coeruleus of cats with interstitial cystitis. J Urol 159: 1045-1048, 1998. 78. Relford R, Robertson J, and Clements C. Symmetric Dimethylarginine Improving the Diagnosis and Staging of Chronic Kidney Disease in Small Animals. Vet Clin N Am-Small 46: 941-960, 2016. 79. Reynolds BS, and Lefebvre HP. Feline CKD: Pathophysiology and risk factors--what do we know? Journal of feline medicine and surgery 15 Suppl 1: 3-14, 2013. 80. Sánchez-Lara A, Elliott J, Syme H, Brown C, and Haylor J. Feline Chronic Kidney Disease Is Associated With Upregulation of Transglutaminase 2 A Collagen Cross-Linking Enzyme. Veterinary pathology 52: 524-534, 2015. 81. Sakaguchi S, Koide R, and Miyazawa T. In vitro host range of feline morbillivirus. The Journal of veterinary medical science / the Japanese Society of Veterinary Science 2015. 82. Sakaguchi S, Nakagawa S, Yoshikawa R, Kuwahara C, Hagiwara H, Asai K, Kawakami K, Yamamoto Y, Ogawa M, and Miyazawa T. Genetic diversity of feline morbilliviruses isolated in Japan. The Journal of general virology 95: 1464-1468, 2014. 83. Sanderson SL. Measuring glomerular filtration rate: practical use of clearance tests. In: Bonagura JD, & Twedt, D. C., ed. Kirk's Current Veterinary Therapy XIV. Elsevier Health Sciences, St Louis (MO), 2009. 84. Sato H, Yoneda M, Honda T, and Kai C. Morbillivirus receptors and tropism: multiple pathways for infection. Frontiers in microbiology 3: 75, 2012. 85. Sawashima K, Mizuno S, Mizuno-Horikawa Y, Shimada A, Kudo T, and Kurosawa T. Expression of alpha-smooth muscle actin and fibronectin in tubulointerstitial lesions of cats with chronic renal failure. American journal of veterinary research 61: 1080-1086, 2000. 86. Sharp CR, Nambulli S, Acciardo AS, Rennick LJ, Drexler JF, Rima BK, Williams T, and Duprex WP. Chronic Infection of Domestic Cats with Feline Morbillivirus, United States. Emerging infectious diseases 22: 760-762, 2016. 87. Siebelink KH, Chu IH, Rimmelzwaan GF, Weijer K, van Herwijnen R, Knell P, Egberink HF, Bosch ML, and Osterhaus AD. Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res Hum Retroviruses 6: 1373-1378, 1990. 88. Sieg M, Heenemann K, Ruckner A, Burgener I, Oechtering G, and Vahlenkamp TW. Discovery of new feline paramyxoviruses in domestic cats with chronic kidney disease. Virus Genes 51: 294-297, 2015. 89. Sparkes A. Feline idiopathic cystitis: Epidemiology, risk factors, and pathogenesis. In: Hill’s Global Symposium on Feline Lower Urinary Tract Health Proceedings. Prague: 2014, p. 7-11. 90. Syme HM, Markwell PJ, Pfeiffer D, and Elliott J. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 20: 528-535, 2006. 91. Tampe D, and Zeisberg M. Potential approaches to reverse or repair renal fibrosis. Nat Rev Nephrol 10: 226-237, 2014. 92. Tencer J, Torffvit O, Grubb A, Bjornsson S, Thysell H, and Rippe B. Decreased excretion of urine glycosaminoglycans as marker in renal amyloidosis. Nephrol Dial Transplant 12: 1161-1166, 1997. 93. Vanholder R, Argiles A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jorres A, Massy ZA, Rodriguez M, Stegmayr B, Stenvinkel P, and Wratten ML. Uremic toxicity: present state of the art. Int J Artif Organs 24: 695-725, 2001. 94. Vanholder R, Van Laecke S, and Glorieux G. The middle-molecule hypothesis 30 years after: lost and rediscovered in the universe of uremic toxicity? J Nephrol 21: 146-160, 2008. 95. Vanholder R, Van Laecke S, and Glorieux G. What is new in uremic toxicity? Pediatr Nephrol 23: 1211-1221, 2008. 96. Verroust PJ, and Christensen EI. Megalin and cubilin - the story of two multipurpose receptors unfolds. Nephrol Dial Transpl 17: 1867-1871, 2002. 97. Virtue ER, Marsh GA, and Wang LF. Paramyxoviruses infecting humans: the old, the new and the unknown. Future microbiology 4: 537-554, 2009. 98. von Messling V, Milosevic D, Devaux P, and Cattaneo R. Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function. Journal of virology 78: 7894-7903, 2004. 99. Westropp JL, Kass PH, and Buffington CA. Evaluation of the effects of stress in cats with idiopathic cystitis. American journal of veterinary research 67: 731-736, 2006. 100. Westropp JL, Kass PH, and Buffington CA. In vivo evaluation of alpha(2)-adrenoceptors in cats with idiopathic cystitis. American journal of veterinary research 68: 203-207, 2007. 101. Westropp JL, and Tony Buffington CA. Feline idiopathic cystitis: current understanding of pathophysiology and management. The Veterinary clinics of North America Small animal practice 34: 1043-1055, 2004. 102. Westropp JL, Welk KA, and Buffington CA. Small adrenal glands in cats with feline interstitial cystitis. J Urol 170: 2494-2497, 2003. 103. White JD, Malik R, Norris JM, and Malikides N. Association between naturally occurring chronic kidney disease and feline immunodeficiency virus infection status in cats. Javma-J Am Vet Med A 236: 424-429, 2010. 104. White JD, Norris JM, Bosward KL, Fleay R, Lauer C, and Malik R. Persistent haematuria and proteinuria due to glomerular disease in related Abyssinian cats. Journal of feline medicine and surgery 10: 219-229, 2008. 105. Whittemore JC, Hawley JR, Jensen WA, and Lappin MR. Antibodies against Crandell Rees feline kidney (CRFK) cell line antigens, alpha-enolase, and annexin A2 in vaccinated and CRFK hyperinoculated cats. Journal of veterinary internal medicine / American College of Veterinary Internal Medicine 24: 306-313, 2010. 106. Willard MD, and Tvedten H. Leukocyte Disorders. In: ed. Small animal clinical diagnosis by laboratory methods. Elsevier Health Sciences, St. Louis, Missouri, 63-91, 2012. 107. Woo PC, Lau SK, Wong BH, Fan RY, Wong AY, Zhang AJ, Wu Y, Choi GK, Li KS, Hui J, Wang M, Zheng BJ, Chan KH, and Yuen KY. Feline morbillivirus, a previously undescribed paramyxovirus associated with tubulointerstitial nephritis in domestic cats. Proceedings of the National Academy of Sciences of the United States of America 109: 5435-5440, 2012. 108. Yabuki A, Mitani S, Fujiki M, Misumi K, Endo Y, Miyoshi N, and Yamato O. Comparative study of chronic kidney disease in dogs and cats: induction of myofibroblasts. Research in veterinary science 88: 294-299, 2010. 109. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, and Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 19: 2282-2287, 2008. 110. Zeisberg M, and Kalluri R. Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis. Am J Physiol Cell Physiol 304: C216-225, 2013. 111. Zeisberg M, Strutz F, and Muller GA. Role of fibroblast activation in inducing interstitial fibrosis. J Nephrol 13 Suppl 3: S111-120, 2000. 112. Zoja C, Abbate M, and Remuzzi G. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration. Nephrol Dial Transplant 30: 706-712, 2015. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/59713 | - |
dc.description.abstract | 慢性腎病定義為單側或雙側腎臟有結構或功能上的損傷、且持續至少三個月以上,為貓隻最常見的腎病之一,與其他腎臟病變比較,腎小管間質性腎炎為貓隻慢性腎病最主要的特徵。而目前能證明貓慢性腎病因果關係的研究還是十分有限。研究顯示傳染性疾病在慢性腎病可能扮演一種要角色,像是貓免疫不全病毒 (FIV)及貓白血病 (FeLV)。最近在2012年,Woo等人從香港首次從貓隻上分離出貓麻疹病毒 (FmoPV),且由組織病理學的結果推論貓麻疹病毒的感染與腎小管間質性腎炎相關。2013至2016年間,日本、歐洲及美國等國也陸續發表關於貓麻疹病毒存在的報告,除了腎小管間質性腎炎之外,腎炎及貓下泌尿道疾病也被認為可能與貓麻疹病毒相關。因此,確認臺灣是否也有貓麻疹病毒的感染及找出其致病性是有其必要性。本實驗的研究目的是藉由反轉錄聚合酶鏈反應調查臺灣貓隻是否也有貓麻疹病毒的感染,親源性序列分析用來比較陽性檢體的基因歧異度。此外,受感染貓隻的臨床病理檢驗數據及臨床徵狀也皆記錄下來,並藉由統計分析其與泌尿道疾病之相關性。根據我們的實驗結果,自2014至2016年總共從臺大動物醫院收集339隻貓的尿液檢體,其中有九隻經由反轉錄聚合酶鏈反應放大部分貓麻疹病毒L基因片段,確認為貓麻疹病毒陽性感染 (2.65%)。經由親緣性序列分析發現,陽性序列可分為兩群不同的病毒株,一群與香港病毒株相似,另一群則和日本病毒株較相似。另一方面,我們也利用陽性質體設計出新的引子用在即時定量聚合酶鏈反應。在九隻陽性貓當中發現,統計上貓麻疹病毒感染與泌尿道疾病伴隨輕微升高的腎指數有顯著相關性 (p =0.034)。然而,在感染組與未感染組的比較當中,腎指數 (尿素氮、肌酐酸及尿比重)、慢性腎病及貓下泌尿道疾病並沒有發現顯著關聯。此外,其中一隻感染的貓在兩年後仍能從其尿液偵測到特定的貓麻疹病毒基因片段。有兩隻陽性感染的貓出現目前尚未被報告的神經相關症狀。綜合以上實驗結果,我們證實臺灣貓隻也有貓麻疹病毒感染,而且貓麻疹病毒可能與泌尿道疾病相關,此病毒最長能在兩年後持續在同隻病患的尿液中被偵測到。 | zh_TW |
dc.description.abstract | Chronic kidney disease (CKD) is the most common renal disease in cats and tubulointerstitial fibrosis is the most common finding. However, the evidence to demonstrate a cause-and-effect etiology of tubulointerstitial fibrosis was limited. Infections might play a causal role in some cases of CKD, like feline immunodeficiency virus (FIV) and feline leukemia virus (FeLV). Recently, Woo et al. (2012) reported the isolation of feline morbillivirus (FmoPV) in domestic cats in Hong Kong and Main China. The histological findings from the infected cats suggested that there might be a correlation between FmoPV infection and tubulointerstitial nephritis (TIN). During 2013-2016, the studies from Japan, Europe and America also demonstrated evidence for the presence of FmoPV in domestic cats. Except TIN, renal inflammation and feline lower urinary tract disease (FLUTD) may also relate to FmoPV infection. Thus, it is essential to confirm the presence of FmoPV in Taiwan and identify its pathogenicity. The aim of this study is to detect FmoPV from urine samples in Taiwan by RT-PCR. Phylogenetic analysis was used to determine sequence divergences. Furthermore, laboratory parameters and clinical signs from the cats suffered from infection were statistically analyzed for the correlation between FmoPV and urinary disease. Based on our results, partial sequence of FmoPV L gene was detected by RT-PCR from 9 out of 339 urine samples (2.65%) of cats brought to National Taiwan University Veterinary Hospital (NTUVH) during 2014-2016. Two different strains of FmoPV similar with the strains from Hong Kong and Japan respectively were found via phylogenetic analysis. Additionally, by using positive plasmid, quantitative PCR was established with new primers designed by our group. Among nine positive cats, urinary disease with mild increased renal index concentration was significantly correlated to FmoPV infected cats (p =0.034). Nevertheless, there was no significant difference of renal values (BUN, Creatinine and urinary specific gravity) of the number of CKD or FLUTD between infected and non-infected cats. Moreover, target viral genomic fragments of FmoPV still could be detected in urine of one positive cat during two years of follow-up. It’s interesting that two virus positive cats had neurological signs and which was never reported. In conclusion, our findings support that the existence of FmoPV infection in Taiwan. Additionally, FmoPV may relate to urinary disease and is still detected from urine of infected cats after two year. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T09:34:24Z (GMT). No. of bitstreams: 1 ntu-106-R02643020-1.pdf: 3482607 bytes, checksum: 58f70ced225b109609ac491ea75cdc30 (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 口試委員審定書 i
Acknowledgement致謝 ii 中文摘要 iii ABSTRACT v CONTENTS vii LIST OF FIGURES xi LIST OF TABLES xiii Chapter 1 Introduction 1 1.1 Relationship between Feline Morbillivirus and urinary system disease 1 1.2 Aim of this study 2 Chapter 2 Literature review 3 2.1 Feline Morbillivirus 3 2.1.1 Classification of Feline Morbillivirus (FmoPV) 3 2.1.2 Genome properties of FmoPV 5 2.1.3 Isolation of FmoPV 6 2.1.4 Phylogenetic analysis 7 2.1.5 Characterization of FmoPV 8 2.1.6 Epidemiological studies of FmoPV in different countries 11 2.2 Azotemia and uremia 15 2.3 Acute kidney injury (AKI) 15 2.4 Chronic kidney disease (CKD) 17 2.4.1 Introduction 17 2.4.2 Aetiology of feline CKD 18 2.4.3 Pathogenesis of feline CKD 19 2.4.4 Measurement of kidney function 21 2.4.5 Diagnosis of CKD 21 2.4.6 IRIS staging system 22 2.5 Feline lower urinary tract disease (FLUTD) 29 2.5.1 Feline idiopathic cystitis (FIC) 29 2.5.2 Urolithiasis and urethral plugs 30 2.5.3 Bacterial urinary tract infection (UTI) 31 2.5.4 Neoplasia 31 2.5.5 Other causes of FLUTD 32 2.6 Evidence between Feline Morbillivirus and urinary system disease 32 2.7 Current methods to detect FmoPV 34 Chapter 3 Materials and Methods 36 3.1 Sample collection 36 3.2 Data of patients 36 3.2.1 Laboratory measurements 36 3.2.2 Criteria of renal disease 37 3.2.3 Criteria of CKD diagnosis 37 3.2.4 Criteria of FLUTD diagnosis 38 3.2.5 Criteria of urinary disease 38 3.3 Preparation of positive control – TA clone and Transformation 38 3.3.1 Plasmid from Hong Kong University [107] 38 3.3.2 Plasmid from FmoPV positive sample in NTUVH 43 3.4 Detection of FmoPV 44 3.4.1 Algorithm of experimental process (Fig. 11) 44 3.4.2 RNA extraction 46 3.4.3 Conventional RT- nested PCR 47 3.4.4 Electrophoresis 50 3.4.5 DNA purification and sequencing 51 3.5 Genome and Phylogenetic analysis 51 3.6 Quantitative RT-PCR (qPCR) 53 3.6.1 Standard curve of FmoPV plasmid 53 3.6.2 Reverse Transcription of positive urine samples 54 3.6.3 Quantitative PCR (qPCR) of positive urine samples 55 3.7 Statistical methods 55 3.7.1 Statistic descriptives of clinical data 55 3.7.2 Compare variants of renal markers in positive cats 55 3.7.3 Compare different variants between FmoPV (+) and FmoPV (-) cats 56 Chapter 4 Result 57 4.1 Sample collection 57 4.2 Data of patients 57 4.2.1 Sex, breed, age and body weight 57 4.2.2 Urinary diseased cats 57 4.3 Positive control from plasmid 60 4.4 Conventional RT-PCR results 61 4.4.1 Electrophoresis and positive rate of FmoPV 61 4.4.2 Sequence of FmoPV positive cat 64 4.4.3 Phylogenetic analysis of nucleotide sequences 69 4.4.4 Amino acids translated from aligned DNA sequence 70 4.5 Quantitative RT-PCR results 73 4.5.1 Serial dilution of positive control 73 4.5.2 Quantitative PCR (qPCR) of positive urine samples. 76 4.6 Clinical data of positive patient 77 4.6.1 Signalment and urinary-related disease 77 4.6.2 Laboratory parameters of FmoPV positive cats 79 4.6.3 Comparison of renal parameters in FmoPV positive cats 82 4.7 Compare clinical date between FmoPV (+) and FmoPV (-) cats 83 4.7.1 Comparison of nominal levels between FmoPV (+) and FmoPV (-) 83 4.7.2 Comparison of interval scales of signalment, complete blood count (CBC), biochemical parameters and urinalysis 84 4.8 Long-term follow-up of positive cats 88 Chapter 5 Discussion 94 Chapter 6 Conclusion 99 Chapter 7 Reference 100 | |
dc.language.iso | en | |
dc.title | 臺灣貓隻麻疹病毒偵測與疾病相關性 | zh_TW |
dc.title | The Detection of Feline Morbillivirus and Its Disease Correlation in Taiwan | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-1 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 張惠雯(Hui-Wen Chang),徐維莉(Wei-Li Hsu),林昭男(Chao-Nan Lin) | |
dc.subject.keyword | 慢性腎病,貓麻疹病毒,副黏液病毒,腎小管間質性腎炎, | zh_TW |
dc.subject.keyword | Chronic kidney disease,Feline morbillivirus,Paramyxovirus,Tubulointerstitial nephritis, | en |
dc.relation.page | 106 | |
dc.identifier.doi | 10.6342/NTU201700582 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-02-14 | |
dc.contributor.author-college | 獸醫專業學院 | zh_TW |
dc.contributor.author-dept | 臨床動物醫學研究所 | zh_TW |
顯示於系所單位: | 臨床動物醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 3.4 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。